Hyperfine HYPR
NASDAQ HYPR
$0.90 0.00 (-0.04%)
As of: Aug 21, 2026 · 1:38 PM EDT

Hyperfine (HYPR) Total Non-Current Liabilities (2022 - 2026)

Hyperfine's (HYPR) quarterly Total Non-Current Liabilities came in at $26.0 million in Q1 2026, up 152.96% YoY from $10.3 million in Q1 2025, and up 82.94% on a QoQ basis from $14.2 million in Q4 2025.

Hyperfine (HYPR) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Hyperfine (HYPR) has 5 years of Total Non-Current Liabilities data on file, last reported at $26.0 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 152.96% year-over-year to $26.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.0 million (up 152.96% YoY) and the FY2025 annual result came in at $14.2 million, up 45.06% from the prior year.
  • Total Non-Current Liabilities improved to $26.0 million in Q1 2026, from $14.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $26.0 million in Q1 2026 to a low of $9.3 million in Q3 2023.
  • A 5-year average of $11.9 million and a median of $10.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities slumped 30.35% — and 2026, when it soared 152.96%.
  • Tracing HYPR's Total Non-Current Liabilities over 5 years: stood at $13.3 million in 2022, then decreased by 27.06% to $9.7 million in 2023, then rose by 0.48% to $9.8 million in 2024, then soared by 45.06% to $14.2 million in 2025, then jumped by 82.94% to $26.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $26.0 million (Q1 2026), $14.2 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.92 Bn 196.32 Bn 7.27 Bn -
2 Stryker 127.14 Bn 123.66 Bn 4.50 Bn 21.28 Bn
3 Medtronic 119.03 Bn 109.81 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 74.38 Bn 73.84 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.74 Bn 47.49 Bn 1.35 Bn 2.57 Bn
6 Dexcom 35.06 Bn 33.11 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.81 Bn 31.70 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.25 Bn 22.93 Bn 4.55 Bn 9.07 Bn
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 3.44 Bn
10 Hyperfine 90.20 Mn 45.43 Mn 1.98 Mn 26.24 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 26.24 Mn
Mar 31, 2026 25.96 Mn
Dec 31, 2025 14.19 Mn
Sep 30, 2025 14.64 Mn
Jun 30, 2025 10.10 Mn
Mar 31, 2025 10.26 Mn
Dec 31, 2024 9.78 Mn
Sep 30, 2024 11.06 Mn
Jun 30, 2024 9.85 Mn
Mar 31, 2024 9.81 Mn
Dec 31, 2023 9.74 Mn
Sep 30, 2023 9.30 Mn
Jun 30, 2023 9.32 Mn
Mar 31, 2023 9.37 Mn
Sep 30, 2022 13.35 Mn
Jun 30, 2022 11.20 Mn